188 related articles for article (PubMed ID: 8010321)
61. [Storage capabilities of individually prepared infusion solutions].
Bánhalmi Z; Korbély I; Kurucz T; Mohr T
Acta Pharm Hung; 1979 Jul; 49(4):145-59. PubMed ID: 474138
[No Abstract] [Full Text] [Related]
62. [Stability of epinephrine in water solutions].
Miram R
Pharm Prax; 1971; 4():89-91. PubMed ID: 5577936
[No Abstract] [Full Text] [Related]
63. Stability of disopyramide phosphate in cherry syrup.
Mathur LK; Lai PK; Shively CD
Am J Hosp Pharm; 1982 Feb; 39(2):309-10. PubMed ID: 7058805
[No Abstract] [Full Text] [Related]
64. [The preservation of pharmaceutical preparations from microbial contamination].
Bean HS
Ann Pharm Fr; 1967 Apr; 25(4):265-70. PubMed ID: 5616103
[No Abstract] [Full Text] [Related]
65. [Stability of acetylsalicylic acid in dosage forms].
Rak J; Chalabala M
Cesk Farm; 1971; 20(4):154-60. PubMed ID: 5561404
[No Abstract] [Full Text] [Related]
66. [Deterioration of drugs in compounding studied by thin-layer chromatography. 2].
Nakano K
Iryo; 1969 Nov; 23(11):1441-5. PubMed ID: 5370266
[No Abstract] [Full Text] [Related]
67. Stability of thiamine hydrochloride repackaged in disposable syringes.
Nolly RJ; Stach PE; Latiolais CJ; Sokoloski TD; Nahata MC
Am J Hosp Pharm; 1982 Mar; 39(3):471-4. PubMed ID: 7072734
[No Abstract] [Full Text] [Related]
68. Stability of phenylephrine hydrochloride nasal drops.
das Gupta V; Mosier RL
Am J Hosp Pharm; 1972 Oct; 29(10):870-3. PubMed ID: 4116413
[No Abstract] [Full Text] [Related]
69. The stability of phenylephrine. 3. The racemisation reaction.
el-Shibini HA; Daabis NA; Motawi MM
Arzneimittelforschung; 1969 Sep; 19(9):1613-4. PubMed ID: 4981211
[No Abstract] [Full Text] [Related]
70. Stability of ondansetron hydrochloride in a total parenteral nutrient admixture.
Kirkham JC; Rutherford ET; Cunningham GN; Daneshmand KA; Falls AL
Am J Health Syst Pharm; 1995 Jul; 52(14):1557-8. PubMed ID: 7552902
[No Abstract] [Full Text] [Related]
71. Stability of ondansetron hydrochloride and five antineoplastic medications.
Stewart JT; Warren FW; King DT; Fox JL
Am J Health Syst Pharm; 1996 Jun; 53(11):1297-300. PubMed ID: 8725205
[No Abstract] [Full Text] [Related]
72. [Study of the stability and storage life of drug forms with a liquid dispersion medium].
Goren'kov VF; Musatova LA
Farmatsiia; 1973; 22(3):71-6. PubMed ID: 4774745
[No Abstract] [Full Text] [Related]
73. [Biopharmaceutical study of para-aminosalicyclic acid tablets].
Bustos D; Cid E
Farmaco Prat; 1975 Aug; 30(8):388-97. PubMed ID: 1157916
[No Abstract] [Full Text] [Related]
74. Procedures important in the manufacture of ophthalmic preparations.
Rosenberg SJ
Bull Parenter Drug Assoc; 1970; 24(2):94-7. PubMed ID: 5439918
[No Abstract] [Full Text] [Related]
75. [On the stability of tablets containing ascorbic acid].
Szepesy A; Keserü P
Acta Pharm Hung; 1966 Nov; 36(6):264-74. PubMed ID: 5983676
[No Abstract] [Full Text] [Related]
76. [On the stability of parenterals at the time of compounding].
Kodama M; Ogata T
Iryo; 1969 Feb; 23(2):269-72. PubMed ID: 5803154
[No Abstract] [Full Text] [Related]
77. Effect of membrane filtration on 10-mg/ml cefazolin admixtures.
Stennett DJ; Simonson W; Ayres JW
Am J Hosp Pharm; 1979 May; 36(5):657-60. PubMed ID: 453218
[No Abstract] [Full Text] [Related]
78. [Stability of aqueous solutions of tetryzoline hydrochloride].
Andermann G; Richard A; Tritz A
J Pharm Belg; 1982; 37(5):309-16. PubMed ID: 7175667
[No Abstract] [Full Text] [Related]
79. Basics of compounding: potency and stability testing.
Allen LV
Int J Pharm Compd; 2013; 17(3):220-4. PubMed ID: 24046938
[TBL] [Abstract][Full Text] [Related]
80. [Eyedrops in form of ready-made pharmaceutical preparations. 2. Ethylmorphine hydrochloride].
Kulesh KF; Bugrim NA
Farmatsiia; 1968; 17(2):27-32. PubMed ID: 5716550
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
